These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 39085696)

  • 1. Risks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studies.
    Cui MF; Chen LM; Jiang C; Ma BZ; Yuan FW; Zhao C; Liu SM
    Support Care Cancer; 2024 Jul; 32(8):561. PubMed ID: 39085696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
    Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
    Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training.
    Mundell NL; Daly RM; Macpherson H; Fraser SF
    Endocr Relat Cancer; 2017 Apr; 24(4):R145-R155. PubMed ID: 28209634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function.
    Reiss AB; Saeedullah U; Grossfeld DJ; Glass AD; Pinkhasov A; Katz AE
    Clin Transl Oncol; 2022 May; 24(5):733-741. PubMed ID: 34743290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
    Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
    Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?
    McHugh DJ; Root JC; Nelson CJ; Morris MJ
    Cancer; 2018 Apr; 124(7):1326-1334. PubMed ID: 29338083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer.
    Kluger J; Roy A; Chao HH
    Curr Oncol Rep; 2020 Feb; 22(3):24. PubMed ID: 32048059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood.
    Reiss AB; Gulkarov S; Pinkhasov A; Sheehan KM; Srivastava A; De Leon J; Katz AE
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
    Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
    Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
    McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
    Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database.
    Tae BS; Jeon BJ; Shin SH; Choi H; Bae JH; Park JY
    Cancer Res Treat; 2019 Apr; 51(2):593-602. PubMed ID: 30025445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects of hormone therapy in men with prostate cancer: a review.
    Nelson CJ; Lee JS; Gamboa MC; Roth AJ
    Cancer; 2008 Sep; 113(5):1097-106. PubMed ID: 18666210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-gated ion channels as potential biomarkers for ADT-mediated cognitive decline in prostate cancer patients.
    Verma S; Singh V; Nagampalli V; Ponsky LE; Li CR; Chao H; Gupta S
    Mol Carcinog; 2024 Jun; 63(6):1051-1063. PubMed ID: 38482990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study.
    Chao HH; Hu S; Ide JS; Uchio E; Zhang S; Rose M; Concato J; Li CS
    PLoS One; 2013; 8(8):e72032. PubMed ID: 23977199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction.
    Pierro MJ; Kilari D
    Eur Urol Focus; 2023 May; 9(3):409-410. PubMed ID: 37005166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2-year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer.
    Garland SN; Savard J; Eisel SL; Wassersug RJ; Rockwood NJ; Thoms J; Jim HSL; Gonzalez BD
    Cancer; 2021 Dec; 127(24):4656-4664. PubMed ID: 34411294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2).
    Crabb S; Morgan A; Hunter MS; Stefanopoulou E; Griffiths G; Richardson A; Fenlon D; Fleure L; Raftery J; Boxall C; Wilding S; Nuttall J; Eminton Z; Tilt E; O'Neill A; Bacon R; Martin J
    Trials; 2023 Jul; 24(1):450. PubMed ID: 37430353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
    Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
    Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.
    Alibhai SM; Gogov S; Allibhai Z
    Crit Rev Oncol Hematol; 2006 Dec; 60(3):201-15. PubMed ID: 16860998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.
    Wu LM; Diefenbach MA; Gordon WA; Cantor JB; Cherrier MM
    Urol Oncol; 2013 Nov; 31(8):1533-8. PubMed ID: 22975107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.